Vaccines Clinical Trials

A listing of Vaccines medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 569 clinical trials
Sujana-A Phase 1/Phase 2 open-label study to evaluate the safety, tolerability, and efficacy of a single intravenous administration of an investigational medication in adult participants with phenylketonuria (PKU)  

This study is looking for individuals 18 to 65 years old with PKU. Sanofi believes that everyoneshould have the opportunity to take part in clinical trials. It is important to include people whohave been historically under-represented in clinical trials. Sanofi is committed to inclusivity inour studies.If you are interested in …

  • 0 views
  • 13 Nov, 2023
  • 1 location
  • 0 views
  • 02 Mar, 2026
Prospective Research for Elderly (≥65 Years Old) Early Breast Cancer Patients (EEBC)  

The elderly patients over 65 years old with breast cancer have concomitant diseases, poor tolerance to conventional treatment, and the specific prognosis of breast cancer is relatively good. Previous studies on breast cancer have almost excluded elderly breast cancer patients, and conventional treatment schemes cannot meet the clinical diagnosis and …

  • 0 views
  • 16 Jun, 2023
  • 1 location
Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19

There is still no effective antiviral drugs and vaccines against SARS-CoV-2 yet now. This is an obsevational study, the investigators collected the clinical information and clinical outcomes of the COVID-19 patients using anti-2019-nCoV inactivated convalescent plasma.The study is to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in …

acute respiratory syndrome (sars)
pneumonia
antiviral drugs
SARS
covid-19
  • 0 views
  • 16 Feb, 2024
  • 1 location
Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales

The objectives of this study are to characterise immune responses in people with CoV-SARS-2 infection and use this knowledge to advance vaccine design, treatment options, and diagnostic reagents. Eligible participants will include people diagnosed with SARS-CoV-2 infection, and may include recently returned travellers and non-travellers in the community presenting to …

coronavirus infection
SARS
covid-19
acute respiratory syndrome (sars)
  • 0 views
  • 05 Aug, 2020
Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);

This study aims to observe the long-term health-related quality of life (HRQOL) and physical performance in individuals hospitalized due to a COVID-19 infection. Therefore, data is extracted from a study-site standard aftercare program which has been adjusted for this patient population. This comprehensive aftercare program includes education sessions and physical …

  • 0 views
  • 05 Aug, 2020
Survey of Procedures and Resources for Initiating Treatment of HIV in Africa-Malawi

In its 2017 revision of the global guidelines for HIV care and treatment, the World Health Organization (WHO) called for rapid or same-day initiation of antiretroviral treatment (ART) for eligible patients testing positive for HIV. However, to date neither the WHO nor the Malawi Ministry of Health has provided detailed …

antiretroviral agents
  • 0 views
  • 16 Feb, 2024
  • 2 locations
A Study of Immune Responses to the Virus That Causes COVID-19

The information gained from the study can be used to help develop better tests for SARS-CoV-2 infection and COVID-19 disease and may help in developing future vaccines, other prevention strategies, and treatments.

anosmia
acute respiratory syndrome (sars)
cough
headache
dyspnea
  • 0 views
  • 16 Feb, 2024
  • 59 locations
Persistence of Immunogenicity Following Reduced PCV Dosing Schedules in South African Children

This study will evaluate the persistence of immunogenicity following a reduced dosing schedule of 10- or 13-valent Pneumococcal Conjugate Vaccine (PCV10, PCV13). This is the follow-up of a randomized controlled trial in which children received a single priming dose of PCV10 or PCV13 (at 6 or 14 weeks of age) …

pneumococcal
conjugate vaccine
pneumococcal conjugate
vaccination
booster
  • 0 views
  • 16 Feb, 2024
  • 1 location
Rheumatology Patient Registry and Biorepository

To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.

rheumatic diseases
spondylitis
dermatomyositis
psoriatic arthritis
skin disease
  • 0 views
  • 05 Aug, 2020